No insider purchase over the last 90 days. The latest, by Lawal Adeniyi, was filed 24 Mar 2026.
Sono TEK Corp belongs to the Technology sector. Filings by its managers are published through SEC (Form 4). From 22 October 2025 to 22 October 2026, the disclosure feed for Sono TEK Corp logged 45 filings by 11 insiders.
Both sides are active: 1 purchase worth €8,498 and 9 sales worth €207k, from 1 insider and 2 insiders respectively. The net balance comes to €199k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 senior executive among the declarants. Biggest ticket of the year: €80k, sold by Coccio Christopher L and made public on 23 July 2026 (0.12% of market cap).
With 45 filings in twelve months, the company is more active than the median of 24 filings across the 3,171 companies we follow on the same exchange. Over the whole record (from 2016), the tally stands at 7 purchases and 254 sales. The 10-K for the year ended 28 February 2026 shows 20.9 m USD of revenue and 1.8 m USD of net income.
The clock since the last published purchase (24 March 2026) now reads 214 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Sono TEK Corp Buy (bullish), based on 2 analysts. Average price target: US$8.50.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended February 2026 · cache
25 of 423 declarations
Sono-Tek Corp. (ticker: SOTK) is a U.S.-listed company traded on the Nasdaq market in the United States. The company was incorporated in New York in 1975 and is headquartered at Sono-Tek Industrial Park in Milton, New York. It is a relatively small-cap industrial technology company with roughly 90–93 employees in its recent corporate materials, and it reaches customers through direct sales, selected independent distributors, and sales representatives across a worldwide network. ([sono-tek.com](https://www.sono-tek.com/about-us/investors/))
Sono-Tek’s core business is the design and manufacture of ultrasonic coating systems. These systems are used to apply thin films and precision coatings to parts where performance and consistency matter. The company’s product set includes multi-axis coating systems, integrated coating systems, fluxing systems, OEM systems, and related platforms, alongside application consulting services. This combination positions Sono-Tek as a solutions provider rather than a simple equipment vendor. Its technologies are deployed in medical devices, semiconductors, microelectronics, alternative energy, advanced industrial manufacturing, and research applications. ([sono-tek.com](https://www.sono-tek.com/about-us/investors/))
From a competitive standpoint, Sono-Tek operates in a niche market focused on high-precision liquid atomization and thin-film deposition. Its value proposition lies in process control, repeatability, and the ability to scale from R&D tools into higher-ASP production equipment. Management has emphasized that the product mix is gradually shifting toward production systems, which is important for long-term revenue quality. The company has particularly strong exposure to medical device manufacturing, where its equipment is used for coating stents, balloons, diagnostic devices, and drug-delivery platforms. It also serves electronics-related applications and clean-energy coating use cases such as fuel cells, carbon capture, and advanced solar cells. ([sono-tek.com](https://www.sono-tek.com/about-us/investors/))
Geographically, Sono-Tek remains anchored in the United States but has built a meaningful international footprint. The company states that it sells worldwide, and its fiscal 2025 materials indicate that about 39% of sales came from outside the United States and Canada. That level of non-domestic exposure suggests a business model that is increasingly diversified beyond its home market. ([sono-tek.com](https://www.sono-tek.com/wp-content/uploads/2025/06/Corporate-Governance-2025.2.pdf))
Recent developments have been supportive of the investment case. In October 2025, Sono-Tek announced a purchase order worth more than $2.8 million from a major U.S. medical device manufacturer, highlighting repeat demand from an existing customer and continued traction in a strategic end market. In January 2026, the company also reported that shipments of high-ASP in-line coating systems to a major solar energy customer helped drive strong growth in that product line. Separately, Sono-Tek promoted Chris Cichetti to Chief Operating Officer in March 2025, reflecting ongoing management succession and operating execution. For French-speaking investors, SOTK offers a focused U.S. Nasdaq technology story with niche market leadership, a broad end-market spread, and growing international relevance. ([sono-tek.com](https://www.sono-tek.com/sono-tek-wins-2-8-million-order-for-advanced-medical-device-coating-systems/?utm_source=openai))
Insider filings
Over the last 90 days, 36 filings published between 27 July and 19 October 2026: 3 sales for €59k. 33 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: Bagley Stephen James (CFO), sales of €59k.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 22 October 2026 (UTC)
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Feb 2026 | 20.9 m USD | 1.8 m USD | 0.11 USD | 10-K |
| Feb 2025 | 20.5 m USD | 1.3 m USD | 0.08 USD | 10-K |
| Feb 2024 | 19.7 m USD | 1.4 m USD | 0.09 USD | 10-K |
| Feb 2023 | 15.1 m USD | 635,905 USD | 0.04 USD | 10-K |
| Feb 2022 | 17.1 m USD | 2.5 m USD | 0.16 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.